Mark Mansour

1.3k total citations
10 papers, 182 citations indexed

About

Mark Mansour is a scholar working on Surgery, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Mark Mansour has authored 10 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Pathology and Forensic Medicine and 2 papers in Dermatology. Recurrent topics in Mark Mansour's work include Multiple Myeloma Research and Treatments (2 papers), Diagnosis and Treatment of Venous Diseases (2 papers) and Cancer Genomics and Diagnostics (2 papers). Mark Mansour is often cited by papers focused on Multiple Myeloma Research and Treatments (2 papers), Diagnosis and Treatment of Venous Diseases (2 papers) and Cancer Genomics and Diagnostics (2 papers). Mark Mansour collaborates with scholars based in Canada, United States and Chile. Mark Mansour's co-authors include Mark Dowar, Jessica Liu, Olena Kis, Zhihua Li, Signy Chow, Suzanne Kamel‐Reid, Rayan Kaedbey, Tong Zhang, Esther Masih‐Khan and Arnavaz Danesh and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of the American Academy of Dermatology.

In The Last Decade

Mark Mansour

9 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Mansour Canada	6	86	63	57	36	31	10	182
Julia Ellermann Germany	3	29 0.3×	119 1.9×	70 1.2×	60 1.7×	55 1.8×	3	251
Maciej Cabanski Switzerland	7	34 0.4×	103 1.6×	75 1.3×	34 0.9×	56 1.8×	9	316
Mitsuteru Hiwatari Japan	8	47 0.5×	137 2.2×	42 0.7×	49 1.4×	29 0.9×	23	251
Marcin M. Machnicki Poland	8	29 0.3×	55 0.9×	16 0.3×	36 1.0×	26 0.8×	25	142
Wen Xing China	8	74 0.9×	136 2.2×	29 0.5×	35 1.0×	15 0.5×	30	274
Shereen Gheith United States	7	37 0.4×	72 1.1×	21 0.4×	61 1.7×	63 2.0×	17	284
Stacey Kalambakas United States	9	69 0.8×	163 2.6×	24 0.4×	60 1.7×	40 1.3×	17	295
Xianggui Yuan China	8	41 0.5×	148 2.3×	113 2.0×	75 2.1×	56 1.8×	21	312
M Soda Japan	5	139 1.6×	172 2.7×	58 1.0×	66 1.8×	76 2.5×	9	312
Borhane Slama France	7	147 1.7×	91 1.4×	11 0.2×	25 0.7×	20 0.6×	29	240

Countries citing papers authored by Mark Mansour

Since Specialization

Citations

This map shows the geographic impact of Mark Mansour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mansour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mansour more than expected).

Fields of papers citing papers by Mark Mansour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Mansour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mansour. The network helps show where Mark Mansour may publish in the future.

Co-authorship network of co-authors of Mark Mansour

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Mansour. A scholar is included among the top collaborators of Mark Mansour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Mansour. Mark Mansour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Mansour, Mark, Khalad Maliyar, Muskaan Sachdeva, et al.. (2024). 53838 Real-world drug survival of risankizumab at a tertiary care psoriasis clinic in Toronto, Canada. Journal of the American Academy of Dermatology. 91(3). AB294–AB294.

Mansour, Mark, et al.. (2020). Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series. American Journal of Clinical Dermatology. 22(2). 275–283. 10 indexed citations

Mansour, Mark, et al.. (2020). SUN-273 PATIENTS TREATED WITH THERAPEUTIC PLASMA EXCHANGE -A SINGLE CENTER EXPERIENCE. Kidney International Reports. 5(3). S313–S313. 1 indexed citations

Pope, Elena, Mark Mansour, Carmen Liy‐Wong, et al.. (2020). Outcomes and Predictors for Re‐stenosis of Esophageal Stricture in Epidermolysis Bullosa. Journal of Pediatric Gastroenterology and Nutrition. 71(3). 310–314. 7 indexed citations

Mansour, Mark & Afsáneh Alavi. (2019). <p>Martorell ulcer: chronic wound management and rehabilitation</p>. SHILAP Revista de lepidopterología. Volume 6. 83–88. 2 indexed citations

Mansour, Mark, Francesco Zulian, Suzanne C. Li, et al.. (2018). Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review. Pediatric Dermatology. 35(6). 761–768. 13 indexed citations

Kis, Olena, Rayan Kaedbey, Signy Chow, et al.. (2017). Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates. Nature Communications. 8(1). 15086–15086. 100 indexed citations

Riff, Karen W. Y. Wong, Mark Mansour, Christopher R. Forrest, et al.. (2016). Content Validity of Patient-Reported Outcome Instruments used with Pediatric Patients with Facial Differences. The Cleft Palate-Craniofacial Journal. 55(7). 989–998. 13 indexed citations

Kaedbey, Rayan, Olena Kis, Arnavaz Danesh, et al.. (2015). Noninvasive diagnosis of actionable mutations by deep sequencing of circulating cell free DNA (cfDNA) in multiple myeloma (MM). Clinical Lymphoma Myeloma & Leukemia. 15. e45–e46. 3 indexed citations

10.

Mansour, Mark, Gurtej S. Cheema, Stanley M. Naguwa, et al.. (2006). Ankylosing Spondylitis: A Contemporary Perspective on Diagnosis and Treatment. Seminars in Arthritis and Rheumatism. 36(4). 210–223. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact